Lim B, Manheimer E, Lao L, Ziea E, Wisniewski J, Liu J, Berman B
University of Maryland School of Medicine, Center for Integrative Medicine, Kernan Hospital Mansion, 2200 Kernan Drive, Baltimore, Maryland 21207-6697, USA.
Cochrane Database Syst Rev. 2006 Oct 18(4):CD005111. doi: 10.1002/14651858.CD005111.pub2.
Irritable bowel syndrome (IBS), a disorder of altered bowel habits associated with abdominal pain or discomfort. The pain, discomfort, and impairment from IBS often lead to healthcare medical consultation (Talley 1997) and workplace absenteeism, and associated economic costs (Leong 2003). A recent randomized controlled trial shows variable results but no clear evidence in support of acupuncture as an effective treatment for IBS (Fireman 2001).
The objective of this systematic review is to determine whether acupuncture is more effective than no treatment, more effective than 'sham' (placebo) acupuncture, and as effective as other interventions used to treat irritable bowel syndrome. Adverse events associated with acupuncture were also assessed.
The following electronic bibliographic databases were searched irrespective of language, date of publication, and publication status: MEDLINE, the Cochrane Central Register of Controlled Trials (CENTRAL) on The Cochrane Library, EMBASE, the Chinese Biomedical Database, the Cumulative Index to Nursing and Allied Health (CINAHL), and the Allied and Complementary Medicine Database (AMED). References in relevant reviews and RCTs were screened by hand. The last date for searching for studies was 7 February 2006.
Published reports of randomized controlled trials (RCTs) and quasi-randomised trials of acupuncture therapy for IBS.
All eligible records identified were dually evaluated for eligibility and dually abstracted. Methodological quality was assessed using the Jadad scale and the Linde Internal Validity Scale. Data from individual trials were combined for meta-analysis when the interventions were sufficiently similar. Heterogeneity was assessed using the I squared statistic.
Six trials were included. The proportion of responders, as assessed by either the global symptom score or the patient-determined treatment success rate, did not show a significant difference between the acupuncture and the sham acupuncture group with a pooled relative risk of 1.28 (95% CI 0.83 to 1.98; n=109). Acupuncture treatment was also not significantly more effective than sham acupuncture for overall general well-being, individual symptoms (e.g., abdominal pain, defecation difficulties, diarrhea, and bloating), the number of improved patients assessed by blinded clinician, or the EuroQol score. For two of the studies without a sham control, acupuncture was more effective than control treatment for the improvement of symptoms: acupuncture versus herbal medication with a RR of 1.14(95% CI 1.00 to 1.31; n=132); acupuncture plus psychotherapy versus psychotherapy alone with a RR of 1.20 (95% CI 1.03 to 1.39; n=100). When the effect of ear acupuncture treatment was compared to an unclearly specified combination of one or more of the drugs diazepam, perphenazine or domperidone, the difference was not statistically significant with a RR of 1.49(95% CI 0.94 to 2.34; n=48).
AUTHORS' CONCLUSIONS: Most of the trials included in this review were of poor quality and were heterogeneous in terms of interventions, controls, and outcomes measured. With the exception of one outcome in common between two trials, data were not combined. Therefore, it is still inconclusive whether acupuncture is more effective than sham acupuncture or other interventions for treating IBS.
肠易激综合征(IBS)是一种与腹痛或不适相关的排便习惯改变的病症。IBS引起的疼痛、不适和功能损害常导致就医咨询(塔利,1997年)以及工作缺勤和相关经济成本(梁,2003年)。最近一项随机对照试验结果不一,但尚无明确证据支持针灸可有效治疗IBS(法尔曼,2001年)。
本系统评价的目的是确定针灸是否比不治疗更有效,是否比“假”(安慰剂)针灸更有效,以及是否与用于治疗肠易激综合征的其他干预措施效果相同。还评估了与针灸相关的不良事件。
检索了以下电子文献数据库,不考虑语言、出版日期和出版状态:医学期刊数据库(MEDLINE)、考克兰图书馆中的考克兰对照试验中心注册库(CENTRAL)、荷兰医学文摘数据库(EMBASE)、中国生物医学文献数据库、护理及相关健康累积索引(CINAHL)以及补充与替代医学数据库(AMED)。通过手工筛选相关综述和随机对照试验中的参考文献。检索研究的最后日期为2006年2月7日。
已发表的针灸治疗IBS的随机对照试验(RCT)和半随机试验报告。
对所有识别出的符合条件的记录进行双重资格评估和双重提取。使用雅达量表和林德内部效度量表评估方法学质量。当干预措施足够相似时,将各个试验的数据合并进行荟萃分析。使用I²统计量评估异质性。
纳入六项试验。根据总体症状评分或患者确定的治疗成功率评估,针灸组和假针灸组的有效应答者比例无显著差异,合并相对风险为1.28(95%置信区间0.83至1.98;n = 109)。在总体健康状况、个体症状(如腹痛、排便困难、腹泻和腹胀)、由盲法临床医生评估的改善患者数量或欧洲五维健康量表评分方面,针灸治疗也不比假针灸显著更有效。对于两项没有假对照的研究,针灸在改善症状方面比对照治疗更有效:针灸与草药治疗,相对风险为1.14(95%置信区间1.00至1.31;n = 132);针灸加心理治疗与单独心理治疗,相对风险为1.20(95%置信区间1.03至1.39;n = 100)。当将耳针治疗的效果与地西泮、奋乃静或多潘立酮中一种或多种药物的不明确指定组合进行比较时,差异无统计学意义,相对风险为1.49(95%置信区间0.94至2.34;n = 48)。
本综述纳入的大多数试验质量较差,在干预措施、对照和测量结果方面存在异质性。除两项试验共有的一个结果外,未合并数据。因此,针灸治疗IBS是否比假针灸或其他干预措施更有效仍无定论。